VJHemOnc is committed to improving our service to you

ESH AL 2020 | Immune checkpoint inhibitors in acute leukemia

VJHemOnc is committed to improving our service to you

Naval Daver

Naval Daver, MD, University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of immune checkpoint inhibitors for the treatment of acute myeloid leukemia (AML). Dr Daver highlights different trials evaluating immune checkpoint inhibitors as well as emerging immune checkpoint pathways. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter